Skip to main content

Fernàndez Garberi, Caterina

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Fernàndez Garberi, Caterina

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.

The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of patients at risk of insufficient response to S1P receptor-modulating therapies.

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

Related professionals

Juan Antonio Hueto Madrid

Juan Antonio Hueto Madrid

Predoctoral researcher
New Technologies and Craniofacial Microsurgery
Read more
Maria Teresa Buongiorno

Maria Teresa Buongiorno

Main researcher
Neurovascular Diseases
Read more
Jordi Mollet Sánchez

Jordi Mollet Sánchez

Predoctoral researcher
Biomedical Research in Melanoma
Read more
Nuria Fernández Hidalgo

Nuria Fernández Hidalgo

Senior researcher
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.